AIDS VACCINE RESEARCH:
Thumbs Down on Expensive, Hotly Debated Trial of NIH AIDS Vaccine
Jon Cohen
When he scuttled plans for a $63 million AIDS vaccine efficacy trial last week, Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, challenged researchers to come up with a "lean and mean" alternative.